Aquestive Therapeutics, Inc. ( AQST) - Key Metrics
AQST Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.11 | -$0.26 | -$0.07 | -$0.07 |
| 2025Q3 | $0.12 | -$0.14 | -$0.11 | -$0.12 |
| 2025Q2 | $0.10 | -$0.14 | -$0.08 | -$0.08 |
| 2025Q1 | $0.09 | -$0.24 | -$0.25 | -$0.25 |
AQST Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.18 |
| 2025Q3 | ? | -10.01 |
| 2025Q2 | ? | -6.07 |
| 2025Q1 | ? | -3.02 |
AQST
Price: $4.14
52 week price:
Earnings Per Share: -0.61 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 208846
Market Capitalization: 518.7 million